alpha-glutamyltryptophan has been researched along with Cancer of Skin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cabriales, S; Espina, BM; Gill, PS; Howard, W; Scadden, DT; Shea, K; Tulpule, A | 1 |
1 trial(s) available for alpha-glutamyltryptophan and Cancer of Skin
Article | Year |
---|---|
Results of a randomized study of IM862 nasal solution in the treatment of AIDS-related Kaposi's sarcoma.
Topics: Administration, Intranasal; Adult; AIDS-Related Opportunistic Infections; Angiogenesis Inhibitors; CD4 Lymphocyte Count; Dipeptides; Disease Progression; Drug Administration Schedule; Endothelial Growth Factors; Fatigue; Female; Headache; HIV Protease Inhibitors; Humans; Lymphokines; Male; Middle Aged; Nausea; Paresthesia; Protein Isoforms; Remission Induction; Sarcoma, Kaposi; Skin Neoplasms; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |